Superior Ophthalmic Vein Embolism Following Forehead Augmentation with Autologous Fat Injection
20
Issued Date
2022-02-01
Resource Type
ISSN
0364216X
eISSN
14325241
Scopus ID
2-s2.0-85109339622
Pubmed ID
34231025
Journal Title
Aesthetic Plastic Surgery
Volume
46
Issue
1
Start Page
450
End Page
455
Rights Holder(s)
SCOPUS
Bibliographic Citation
Aesthetic Plastic Surgery Vol.46 No.1 (2022) , 450-455
Suggested Citation
Putthirangsiwong B. Superior Ophthalmic Vein Embolism Following Forehead Augmentation with Autologous Fat Injection. Aesthetic Plastic Surgery Vol.46 No.1 (2022) , 450-455. 455. doi:10.1007/s00266-021-02414-0 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/86189
Title
Superior Ophthalmic Vein Embolism Following Forehead Augmentation with Autologous Fat Injection
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Background: Facial rejuvenation and reconstruction with autologous fat injection are a common and effective procedure used worldwide. Most surgeons and patients are satisfied with the favorable outcomes. However, catastrophic complications from arterial and venous occlusion resulting in visual loss and stroke may occur. Case presentation: We herein report a case of isolated venous occlusion from fat embolism. The patient developed acute painful proptosis and blurred vision of her right eye while undergoing an esthetic autologous fat injection into her forehead. Based on her clinical manifestations and radiologic findings, the patient was diagnosed with superior ophthalmic vein occlusion. Symptomatic and supportive treatments were given. Spontaneous clinical improvement occurred without secondary complications. Therefore, the initially planned endovascular therapy with transfemoral transvenous embolectomy of the right superior ophthalmic vein was canceled. Conclusions: Facial augmentation with autologous fat injection can cause superior ophthalmic vein embolism. Surgeons should therefore perform this procedure very cautiously. Prompt ophthalmological evaluation and proper management are important for improving clinical outcomes. Level of Evidence V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
